VBI Vaccines Q1 EPS $(0.73) Up From $(3.22) YoY, Sales $1.21M Up From $485.00K YoY
VBI Vaccines Q1 EPS $(0.73) Up From $(3.22) YoY, Sales $1.21M Up From $485.00K YoY
VBI Vaccines第一季度每股收益爲0.73美元，高於同比3.22美元，銷售額爲121萬美元，同比增長48.5萬美元
VBI Vaccines (NASDAQ:VBIV) reported quarterly losses of $(0.73) per share. This is a 77.33 percent increase over losses of $(3.22) per share from the same period last year. The company reported $1.21 million in sales this quarter. This is a 150.31 percent increase over sales of $485.00 thousand the same period last year.
VBI Vaccines（納斯達克股票代碼：VBIV）公佈的季度虧損爲每股0.73美元。這比去年同期每股虧損3.22美元（3.22美元）增長了77.33％。該公司報告本季度銷售額爲121萬美元。這比去年同期的48.5萬美元銷售額增長了150.31％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。